{"organizations": [], "uuid": "05fddde9cc908b2bd77d201886e1ce9f58e431fc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 2, "shares": 2, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://si.wsj.net/public/resources/images/BN-XQ388_282Vb_TOP_20180226184652.jpg", "site_section": "https://www.wsj.com/europe", "section_title": "The Wall Street Journal &amp; Breaking News, Business, Financial and Economic News, World News and Video", "url": "https://www.wsj.com/articles/akorn-shares-plunge-as-fresenius-investigates-company-1519689410", "country": "US", "domain_rank": 387, "title": "Akorn Shares Plunge as Fresenius Investigates Company", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.007, "site_type": "news", "published": "2018-02-27T02:56:00.000+02:00", "replies_count": 0, "uuid": "05fddde9cc908b2bd77d201886e1ce9f58e431fc"}, "author": "Maria Armental", "url": "https://www.wsj.com/articles/akorn-shares-plunge-as-fresenius-investigates-company-1519689410", "ord_in_thread": 0, "title": "Akorn Shares Plunge as Fresenius Investigates Company", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fresenius se & co.", "sentiment": "negative"}, {"name": "akorn shares plunge", "sentiment": "negative"}, {"name": "fresenius investigates company", "sentiment": "negative"}, {"name": "akorn", "sentiment": "none"}, {"name": "akorn inc.", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "German health-care company Fresenius SE & Co. said Monday it is looking into possible product development data breaches at Akorn Inc., a probe that could derail its purchase of the U.S. generic-drugs manufacturer.\nHours later, Akorn issued a statement saying that it also was looking into the matter and that “to date, the company’s investigation has not found any facts that would result in a material impact on Akorn’s operations and the company does not believe this investigation should affect the closing of the transaction... ", "external_links": [], "published": "2018-02-27T02:56:00.000+02:00", "crawled": "2018-02-27T03:19:46.133+02:00", "highlightTitle": ""}